Indacaterol
Side effects
Options:
Show MedDRA Preferred Terms
|
Side effect
|
Data for drug
|
Placebo
|
Labels
|
|
|
1
|
2
|
3
|
|
Upper respiratory tract infection
|
common, 14.2%
|
|
x
|
x
|
x
|
|
Cough
|
common, 6.46% - 8.2%
|
4.49%
|
x
|
x
|
x
|
|
Nasopharyngitis
|
common, 5.35% - 14.3%
|
2.7%
|
x
|
x
|
x
|
|
Chest pain
|
common
|
|
|
x
|
x
|
|
Dizziness
|
postmarketing, common
|
|
x
|
x
|
x
|
|
Gastrointestinal disorder
|
common
|
|
x
|
|
x
|
|
Sinusitis
|
common
|
|
x
|
x
|
x
|
|
Dry mouth
|
common
|
|
|
|
x
|
|
Oedema peripheral
|
common
|
|
x
|
x
|
x
|
|
Malnutrition
|
common
|
|
x
|
x
|
x
|
|
Throat irritation
|
common
|
|
|
x
|
|
|
Rhinorrhoea
|
common
|
|
|
x
|
x
|
|
Oropharyngeal pain
|
common, 2.23%
|
0.674%
|
x
|
x
|
x
|
|
Headache
|
postmarketing — 3.7% - 5.12%
|
2.47%
|
x
|
x
|
x
|
|
Muscle spasms
|
common, 3.5%
|
|
x
|
x
|
x
|
|
Nausea
|
2.45%
|
0.899%
|
x
|
|
|
|
Atrial fibrillation
|
uncommon
|
|
x
|
x
|
x
|
|
Diabetes mellitus
|
uncommon, common
|
|
x
|
x
|
x
|
|
Rash
|
postmarketing, uncommon
|
|
x
|
x
|
x
|
|
Hyperglycaemia
|
uncommon, common
|
|
x
|
x
|
x
|
|
Hypersensitivity
|
postmarketing, uncommon
|
|
x
|
x
|
|
|
Musculoskeletal pain
|
uncommon
|
|
x
|
x
|
x
|
|
Palpitations
|
postmarketing, uncommon
|
|
x
|
x
|
x
|
|
Paraesthesia
|
uncommon
|
|
|
x
|
x
|
|
Pruritus
|
postmarketing, uncommon
|
|
x
|
x
|
x
|
|
Tachycardia
|
postmarketing, uncommon
|
|
x
|
x
|
x
|
|
Myocardial ischaemia
|
uncommon
|
|
|
x
|
x
|
|
Myalgia
|
uncommon
|
|
|
x
|
x
|
|
Bronchospasm paradoxical
|
postmarketing, uncommon
|
|
x
|
x
|
x
|
|
Cardiac disorder
|
postmarketing
|
|
|
x
|
x
|
|
Mediastinal disorder
|
postmarketing
|
|
x
|
x
|
x
|
|
Nervous system disorder
|
postmarketing
|
|
x
|
x
|
x
|
|
Unspecified disorder of skin and subcutaneous tissue
|
postmarketing
|
|
|
x
|
x
|
|
Anaemia
|
|
|
|
|
x
|
|
Angina pectoris
|
|
|
x
|
|
|
|
Bronchospasm
|
|
|
|
|
x
|
|
Infection
|
|
|
x
|
x
|
x
|
|
Connective tissue disorder
|
|
|
x
|
x
|
x
|
|
Dyspnoea
|
|
|
x
|
|
|
|
Hypokalaemia
|
|
|
|
x
|
x
|
|
Immune system disorder
|
|
|
|
x
|
|
|
Pneumonia
|
|
|
x
|
|
|
|
Tremor
|
|
|
|
x
|
x
|
|
Vertigo
|
|
|
|
|
x
|
|
Chest discomfort
|
|
|
|
|
x
|
|
Exacerbation of asthma
|
|
|
x
|
|
|
|
COPD exacerbation
|
|
|
x
|
|
|
|
Infestation NOS
|
|
|
x
|
x
|
x
|
Indications
Information about indications was extracted from the indications and usage sections of the labels.
| Side effects: | 32 |
|---|
| Source: | FDA Structured Product Label |
|---|
| Side effects: | 36 |
|---|
| Source: | EMA |
|---|
| Side effects: | 39 |
|---|
| Source: | medicines.org.au |
|---|
Color scheme:
standard – alternative
|
|
|
100%
|
|
|
|
75%
|
|
|
|
50%
|
|
|
|
10%
|
|
|
|
frequent (1% to 100%)
|
|
|
|
infrequent (0.1% to 1%)
|
|
|
|
rare (<0.1%)
|
|
|
|
postmarketing
|
|
|
|
0%
|
|
|
|
no frequency information
|
|
|
|
not found on label
|
